发明名称 PERORAL MEDICINAL FORMULATIONS WITH SUSTAINED-RELEASE EFFECT
摘要 FIELD: medicine, pharmacy. ^ SUBSTANCE: invention relates to a medicinal formulation with partially sustained-release effect. The pharmaceutical active substance is tramadol that is represented partially in the form of compound formed in situ with water solubility <=100 mg/ml. Tramadol and acid pharmaceutical active substance and/or accessory substance, or their corresponding water-soluble salts and optionally other accessory substances are mixed, wetted some times and the mixture is processed to the end composition using energy supply. ^ EFFECT: reduced cost of process, valuable pharmaceutical properties of formulation. ^ 29 cl, 7 tbl, 7 ex
申请公布号 RU2240786(C2) 申请公布日期 2004.11.27
申请号 RU20020106747 申请日期 2000.08.03
申请人 发明人 TSIGLER IRIS;BARTOLOMOJZ IOGANNES
分类号 A61K9/16;A61K9/20;A61K9/22;A61K9/28;A61K9/30;A61K9/50;A61K9/52;A61K31/135;A61K31/19;A61K31/192;A61K31/195;A61K31/196;A61K31/428;A61K31/60;A61K31/616;A61K47/12;A61K47/20;A61K47/22;A61P1/04;A61P1/12;A61P9/00;A61P11/00;A61P11/14;A61P13/00;A61P13/02;A61P25/00;A61P25/08;A61P25/18;A61P25/24;A61P25/30;A61P25/32;A61P25/36;A61P29/00;A61P37/08 主分类号 A61K9/16
代理机构 代理人
主权项
地址